No Data
No Data
No Data
No Data
No Data
Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children With Febrile Respiratory Infections, Study Shows
International journal Infectious Diseases and Clinical Microbiology has published results of Lumos Diagnostics Holdings' (ASX:LDX) FebriDx study in 216 pediatric patients, according to a Monday Austra
MT NewswiresApr 9 06:37
Lumos Diagnostics Hires Henry Schein as US Distributor for Respiratory Infection Blood Test; Shares Rise 4%
Lumos Diagnostics (ASX:LDX) hired Nasdaq-listed medical supply firm Henry Schein as the US distributor for its FebriDx blood-based respiratory infection diagnostic test. Henry Schein is currently dist
MT NewswiresFeb 12 09:35
Lumos Diagnostics' Q4 Revenue Jumps 55%
Lumos Diagnostics (ASX:LDX) reported Wednesday that its unaudited revenue for the quarter ended Dec. 31, 2023, was $1.7 million, marking a 55% jump from $1.1 million reported in the preceding quarter.
MT NewswiresJan 31 14:08
Australian Shares Rise Ahead of US Inflation Data
Australian shares rose Thursday ahead of the release of key US inflation data to better gauge the direction of future monetary policy. The S&P/ASX 200 Index rose 37.50 points, or 0.5%, to 7,506.00. In
MT NewswiresJan 11 13:46
Lumos Diagnostics Signs Development and IP Agreements With Hologic; Shares Up 24%
Point-of-care diagnostic solutions provider Lumos Diagnostics (ASX:LDX) has signed two new agreements with US-based women's health company Hologic for the development of and intellectual property righ
MT NewswiresJan 11 10:51
Stocks of the Hour: Norfolk Metals, Aspire Mining, Lumos Diagnostics
Norfolk Metals (ASX:NFL) has announced that phase 2 drilling has commenced at the Orroroo Uranium Project. Executive Chairman Ben Phillips comments: "The maiden drill program has proceeded as schedule
sharecafeJan 11 08:30
No Data
No Data